Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $61.71 Analyst target: $65.39 Upside: 5.96%
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
See the full interactive analysis & chart →Informational only — not investment advice.